Atlas Trials

Once-Daily Oral Avatrombopag Tablets Used in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures

Clinical trial NCT00914927 · COMPLETED

Trial details

NCT number
NCT00914927
Sponsor
Eisai Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Thrombocytopenia Related to Chronic Liver Disease
Start date
2009-05-01
Primary completion
2011-11-11
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.